Compare Clean Science with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 12.13% and Operating profit at 2.36% over the last 5 years
Flat results in Mar 26
With ROE of 17.7, it has a Very Expensive valuation with a 5.8 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 8,820 Cr (Small Cap)
36.00
42
0.73%
-0.25
17.68%
5.84
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Feb-06-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Clean Science Q4 FY26: Margin Recovery Masks Deeper Profit Concerns
Clean Science and Technology Ltd. reported a mixed fourth quarter for FY26, with net profit climbing 27.01% quarter-on-quarter to ₹58.27 crores but falling 21.35% year-on-year, highlighting persistent challenges in sustaining profitability despite operational improvements. The specialty chemicals manufacturer, commanding a market capitalisation of ₹8,820 crores, saw its stock trade at ₹820.40 on May 14, down a staggering 48.69% from its 52-week high of ₹1,599.00, reflecting investor concerns over the company's ability to replicate its historical growth trajectory.
Read full news article
Clean Science & Technology Ltd is Rated Sell
Clean Science & Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with the most recent and relevant data to assess the company’s outlook.
Read full news article
Clean Science & Technology Ltd is Rated Sell
Clean Science & Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with the latest comprehensive analysis.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
29-Apr-2026 | Source : BSEIn terms of the referred Regulation 30 read with Schedule III - Part A of SEBI Listing Regulations 2015 we would like to inform you that a conference call for analysts and investors has been scheduled on Thursday 14th May 2026 at 4:00 P.M. (IST) to discuss the audited financial results for the Quarter and Financial year ended 31st March 2026.
Clarification sought from Clean Science and Technology Ltd
24-Apr-2026 | Source : BSEThe Exchange has sought clarification from Clean Science and Technology Ltd on April 24 2026 with reference to Movement in Volume.
The reply is awaited.
Clarification About Significant Increase In Volume Of Security.
24-Apr-2026 | Source : BSEEnclosed is the clarification about significant increase in volume of security.
Corporate Actions 
No Upcoming Board Meetings
Clean Science & Technology Ltd has declared 200% dividend, ex-date: 06 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
0.6421
Held by 18 Schemes (12.49%)
Held by 101 FIIs (13.39%)
Ashokkumar Ramkishan Sikchi Huf (9.96%)
Amansa Holdings Private Limited (4.37%)
11.24%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 13.47% vs -10.25% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 27.01% vs -17.23% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 5.48% vs 25.17% in Sep 2024
Growth in half year ended Sep 2025 is 0.66% vs 12.19% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.59% vs 24.65% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -9.95% vs 9.53% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -1.04% vs 22.13% in Mar 2025
YoY Growth in year ended Mar 2026 is -13.14% vs 8.35% in Mar 2025






